Schizophrenia News and Research

Latest Schizophrenia News and Research

Electroconvulsive therapy helps patients with severe depression who don't respond to other treatments

Electroconvulsive therapy has been shown to be a highly effective, safe, and even life-saving treatment for persistent and severe depression, bipolar disorder, and schizophrenia.

8 May 2007

Increasing SUMO protein in brain could be a way of treating epilepsy and schizophrenia

The brain contains about 100 million nerve cells, each having 10,000 connections to other nerves cells. These connections, called synapses, chemically transmit the information that controls all brain function via proteins called receptors. These processes are believed to be the basis of learning and memory.

7 May 2007

Study of damaged gene gives insight into causes of mental illness

Scientists have pinpointed how different types of damage in types of damage to the same gene can cause some people to suffer from schizophrenia while others have major depression.

4 May 2007

Gene malfunctions cause schizophrenia, depression symptoms in mice

Researchers have demonstrated for the first time that malfunction of a gene that had been associated with schizophrenia and depression does indeed cause symptoms of those disorders.

4 May 2007

New compounds show potential for cognitive disorders

UC Irvine researchers have identified a new class of compounds that could be used for drugs to treat cognitive disorders that accompany schizophrenia, Alzheimer's disease and ADHD, according to an article published today in the online version of the Proceedings of the National Academy of Sciences.

2 May 2007

INVEGA granted positive opinion recommending approval in Europe

Janssen-Cilag International NV has announced that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA (paliperidone prolonged release tablets).

30 Apr 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Heavy use of cannabis triggers psychotic illnesses

Scientists in the UK say the heavy consumption of the drug cannabis may trigger psychotic illnesses such as schizophrenia.

30 Apr 2007

Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure

In a first-of-its-kind study on humans, researchers measured how dopamine-related drugs affect the striatum, a part of the brain that is stimulated by rewards.

27 Apr 2007

Report identifies schizophrenia patients likely to receive depot medication

A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.

26 Apr 2007

Psychotherapeutic drug spending surges

Spending on prescription drugs to treat depression, anxiety, pain, schizophrenia and other conditions climbed from $7.9 billion in 1997 to $20 billion in 2004 - over a 150 percent increase, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

25 Apr 2007

Swedish Big Brother behind lobotomies in the 1940s and 1950s

Sweden was more accepting than the U.S. in its attitude toward lobotomy in the 1940s and 1950s. A possible explanation for this may be the strength of paternalism in Sweden, that is, a greater tendency to make decisions on behalf of the patient in Swedish medical culture than in its American counterpart. This is according to Kenneth Ogren from Umea University in Sweden.

25 Apr 2007

New understanding of schizophrenia

New research helps bridge an important gap in understanding schizophrenia, providing the best evidence to date that defects in the brain's white matter are a key contributor to the disease, which affects about 1 percent of people worldwide.

24 Apr 2007

Discovery of molecular mechanism that alters strength of higher brain network connections

Yale School of Medicine and University of Crete School of Medicine researchers report in Cell April 20 the first evidence of a molecular mechanism that dynamically alters the strength of higher brain network connections.

21 Apr 2007

Bill broadening prescribing rights to psychologists unsafe

Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.

20 Apr 2007

New insights into how the brain controls movements

In the children's game "red light green light," winners are able to stop, and take off running again, more quickly than their comrades.

19 Apr 2007

Internal part of prefrontal cortex identified as key structure for memory formation

Does a specific memory exist for events involving humans, French researchers from the Vulnerability, Adaptation and Psychopathology Laboratory (CNRS/Universit' Paris VI) and Canadian researchers from Douglas Hospital, McGill University (Montreal) have identified the internal part of the prefrontal cortex as the key structure for the memory formation of social information.

19 Apr 2007

New device to test for proteins that play important role in human health and disease

A new technology developed at the University of Toronto is revealing biochemical processes responsible for diseases such as cystic fibrosis and could one day pave the way for pharmaceutical applications.

15 Apr 2007

Full impact of mental health and substance abuse disorders on U.S. community hospitals

Almost one-fourth of all stays in U.S. community hospitals for patients age 18 and older – 7.6 million of nearly 32 million stays – involved depressive, bipolar, schizophrenia and other mental health disorders or substance use related disorders in 2004, according to a new report by HHS' Agency for Healthcare Research and Quality.

11 Apr 2007

MIT model helps see how folds develop and decay in the cerebral cortex

Large mammals--humans, monkeys, and even cats--have brains with a somewhat mysterious feature: The outermost layer has a folded surface. Understanding the functional significance of these folds is one of the big open questions in neuroscience.

10 Apr 2007